久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

chinadaily.com.cn
left corner left corner
China Daily Website

Medical reforms spell out profit for pharma giants

Updated: 2013-04-13 14:37
By Liu Jie ( China Daily)

China now has 148 million people with pre-diabetes on top of an existing 92.4 million diabetes patients.

The number of patients is forecast to reach 130 million by 2030, creating medical costs related to type-2 diabetes of $47.2 billion, according to International Diabetes Federation.

In the China National Plan for Chronic Diseases Prevention and Treatment (2012-2015), diabetes has been given specific importance.

"Our advantage is in early-stage diabetes treatment. Our Glucophage (an oral diabetes medicine that helps control blood sugar levels) is recommended as initial treatment within national guidelines," said Jean-Christophe Pointeau, president of Bristol-Myers China.

The medicine is on China's essential drug list and Pointeau said he expects another Bristol-Myers product - Onglyza, a prescription type 2 diabetes medicine - also to be included.

Another major international name, Boston Scientific Co, has just announced clinical results of a trial evaluating the safety and effectiveness of a cardiovascular stent system in China.

Clinical trials are the prerequisite of new product introduction.

The US company is also working to introduce more specialist treatment to the Chinese market, including those involved in cardiology and endoscopy, especially in the treatment of chronic conditions, said Michael F. Mahoney, Boston Scientific's CEO.

Since entering China in 1997, the company's average annual growth by sales has kept at 30 percent and it expects to exceed that figure in coming years.

The company is also building a research and development, training and head office complex in Shanghai, which is expected to be completed in September.

China expects to increase its medical spending by 27 percent this year, and to more than double the number of drugs in its national reimbursement medicine list from 205 to 520.

China's medical insurance will cover an additional 20 serious illnesses, including lung and gastric cancers, chronic myelocytic leukemia, hemophilia, type-1 diabetes and cerebral infarction.

These are also other serious diseases seeing increased occurrence in China, which lack high-quality diagnosis and treatment equipment being produced by domestic companies, according to a recent report from Bank of China International (China) Ltd.

Sanofi's Lam added that so far the company cannot assess how successful its investment in the Chinese market has been, "but we believe in the long run, it will be absolutely positive to us".

Sanofi's diabetes business increased 25 percent year-on-year in 2012, compared with the average growth of the sector at 15 percent.

 
8.03K
 
...
主站蜘蛛池模板: 亚洲三级小视频 | 国产精品中文字幕在线观看 | 久久久久成人精品一区二区 | 亚洲第一成年网站大全亚洲 | 欧美日韩日本国产 | 一色屋成人免费精品网 | 日本三级香港三级网站 | 99在线观看精品视频 | 99热久久精品国产 | 亚洲最大的视频网站 | 亚洲精品国产成人 | 久草一级片 | 国产一级毛片午夜福 | 久久成人小视频 | 在线播放亚洲美女视频网站 | 成人高清视频免费观看 | 精品免费在线视频 | 欧美高清视频手机在在线 | 亚洲第一成人天堂第一 | 欧美日韩精品一区二区三区不卡 | 在线观看片成人免费视频 | ririai99在线视频观看 | 欧美精品一区二区三区在线 | 大陆老太xxxxxxxxhd | 亚洲天堂网站在线 | 国产精品青草久久久久福利99 | 成人一级网站 | 欧美成人网7777视频 | 日韩精品a | 怡红院免费的全部视频国产a | 2019在线亚洲成年视频网站 | 久久亚洲精品成人 | 国产精品国产精品国产三级普 | 日韩v在线| 国产99视频精品免费观看9e | 波多野结衣视频在线 | 99免费在线播放99久久免费 | 亚洲欧洲精品国产二码 | 国产亚洲精品久久久久久久久激情 | 九九九免费视频 | 精品免费久久久久久成人影院 |